APA (7th ed.) Citation

Kosloski, M. P., Zhao, W., Marbury, T. C., Preston, R. A., Collins, M. G., Pugatch, D., . . . Liu, W. (2018). Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects. Antimicrobial agents and chemotherapy, 62(3), . https://doi.org/10.1128/AAC.01990-17

Chicago Style (17th ed.) Citation

Kosloski, Matthew P., Weihan Zhao, Thomas C. Marbury, Richard A. Preston, Michael G. Collins, David Pugatch, Federico Mensa, Jens Kort, and Wei Liu. "Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects." Antimicrobial Agents and Chemotherapy 62, no. 3 (2018). https://doi.org/10.1128/AAC.01990-17.

MLA (9th ed.) Citation

Kosloski, Matthew P., et al. "Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects." Antimicrobial Agents and Chemotherapy, vol. 62, no. 3, 2018, https://doi.org/10.1128/AAC.01990-17.